Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis

NCT03031444 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Stage IV
Metastasis

Interventions

DRUG: Cetuximab plus FOLFIRI/FOLFOX
DRUG: FOLFIRI/FOLFOX/CapeOX

Sponsor

Peking University Cancer Hospital & Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]